TY - JOUR
TI - Comment on “rituximab maintenance for patients with aggressive B-cell lymphoma in first remission: Results of the randomized NHL13 trial”
AU - Vassilakopoulos, T.P.
AU - Apostolidis, J.
AU - Angelopoulou, M.K.
JO - Haematologica-the hematology journal
PY - 2015
VL - 100
TODO - 11
SP - e480-e481
PB - Ferrata Storti Foundation
SN - null
TODO - 10.3324/haematol.2015.133223
TODO - rituximab;  antineoplastic agent;  rituximab, B cell lymphoma;  bone marrow;  clinical trial (topic);  drug efficacy;  event free survival;  female;  gender;  human;  large cell lymphoma;  Letter;  male;  overall survival;  unspecified side effect;  Lymphoma, Follicular;  Lymphoma, Large B-Cell, Diffuse, Antineoplastic Combined Chemotherapy Protocols;  Female;  Humans;  Lymphoma, Follicular;  Lymphoma, Large B-Cell, Diffuse;  Male;  Rituximab
TODO - null
ER -